Evaluation of Antitumor Effects of Half-Sandwich Ruthenium (II) Complexes in Comparison to Platinum-Based Drugs
International Journal of Natural Sciences and Mathematics · 25.03.2026 · 1 (2) · 69-90
DOI: 10.64394/ijnsm.v1i2.84 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Natural Sciences and Mathematics, online erschienen am 25.03.2026. Verfasst von Mohammad Ali Nasiri und 3 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Half-sandwich ruthenium (II) complexes have emerged as promising alternatives to platinum-based drugs in anticancer research due to their potential for reduced toxicity and novel mechanisms of action. This narrative review compares the antitumor effects of Ru(II) complexes to those of conventional platinum-based chemotherapeutics, such as cisplatin and oxaliplatin. We analyze their structural features, modes of action (including DNA interaction, protein binding, and ROS generation), and in vitro/in vivo efficacy against various cancer models. Notably, Ru (II) complexes demonstrate distinct advantages, such as improved selectivity, resistance profile, and activity against platinum-resistant cancers. However, challenges regarding bioavailability and pharmacokinetics remain. Studies indicate that these complexes exert their anticancer effects through multiple key pathways, including p53-independent apoptosis induction in cisplatin-resistant cells, inhibition of angiogenesis via VEGF downregulation, induction of oxidative stress through reactive oxygen species (ROS) generation, and modulation of metastatic signaling pathways (particularly MMP-2/9). Preclinical models have demonstrated significant activity of [Imidazo [4,5-f][1,10] phenanthroline]Ru (II) complexes against treatment-resistant cancers, especially ovarian and colorectal malignancies.
Zitieren
APA
Nasiri, M. A., Yosufi, A., Rashid, A., & Moin, B. A. (2026). Evaluation of Antitumor Effects of Half-Sandwich Ruthenium (II) Complexes in Comparison to Platinum-Based Drugs. International Journal of Natural Sciences and Mathematics, 1(2), 69-90. https://doi.org/10.64394/ijnsm.v1i2.84
Vancouver
Nasiri MA, Yosufi A, Rashid A, Moin BA. Evaluation of Antitumor Effects of Half-Sandwich Ruthenium (II) Complexes in Comparison to Platinum-Based Drugs. International Journal of Natural Sciences and Mathematics. 2026;1(2):69-90. doi:10.64394/ijnsm.v1i2.84
BibTeX
@article{Nasiri2026,
author = {Nasiri, Mohammad Ali and Yosufi, Azizullah and Rashid, Abdulraouf and Moin, Bonyad Ali},
title = {Evaluation of Antitumor Effects of Half-Sandwich Ruthenium (II) Complexes in Comparison to Platinum-Based Drugs},
journal = {International Journal of Natural Sciences and Mathematics},
year = {2026},
volume = {1},
number = {2},
pages = {69--90},
doi = {10.64394/ijnsm.v1i2.84}
}
EUVIMED